| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ATP6V1G2-DDX39B readthrough (NMD candidate) | 0.769 | 0.423 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | |||||||||
|
HLA complex group 9 | 0.700 | 0.500 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2010 | 2010 | |||||||||
|
PPT2-EGFL8 readthrough (NMD candidate) | 0.792 | 0.462 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2010 | 2010 | |||||||||
|
MHC class I polypeptide-related sequence C (pseudogene) | 0.890 | 0.154 |
|
disease | 0.100 | None | 1.000 | 1 | 3 | 2010 | 2010 | |||||||||
|
long intergenic non-protein coding RNA 1149 | 0.792 | 0.346 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | |||||||||
|
butyrophilin like 2 | 0.546 | 0.808 | 8.6E-11 |
|
disease | 0.110 | None | 1.000 | 3 | 2 | 2010 | 2012 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.140 | None | 1.000 | 3 | 3 | 1999 | 2012 | ||||||||
|
TSBP1 and BTNL2 antisense RNA 1 | 0.638 | 0.692 |
|
disease | 0.100 | None | 1.000 | 3 | 3 | 2010 | 2012 | |||||||||
|
FGFR1 oncogene partner | 0.656 | 0.577 | 6.3E-04 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2010 | 2012 | ||||||||
|
ataxin 2 | 0.482 | 0.808 | 0.85 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.120 | None | 1.000 | 1 | 3 | 2010 | 2012 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
toll like receptor adaptor molecule 1 | 0.593 | 0.846 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||||||
|
RPGRIP1 like | 0.534 | 0.769 | 4.1E-31 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
solute carrier family 29 member 3 | 0.578 | 0.769 | 1.3E-07 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
SPARC related modular calcium binding 2 | 0.670 | 0.462 | 2.5E-03 |
|
disease | 0.120 | None | 1.000 | 1 | 1 | 2010 | 2013 | ||||||||
|
zinc finger MIZ-type containing 1 | 0.588 | 0.615 | 1.00 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2010 | 2014 | ||||||||
|
LIM domain containing preferred translocation partner in lipoma | 0.543 | 0.769 | 7.2E-03 |
|
disease | 0.100 | None | 1.000 | 4 | 5 | 2010 | 2016 | ||||||||
|
ubiquitin associated and SH3 domain containing A | 0.638 | 0.538 | 1.0E-10 |
|
disease | 0.100 | None | 1.000 | 3 | 2 | 2010 | 2016 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.100 | None | 1.000 | 3 | 1 | 2010 | 2016 | ||||||||
|
C1q and TNF related 6 | 0.682 | 0.577 | 9.0E-06 |
|
disease | 0.100 | None | 1.000 | 3 | 1 | 2010 | 2016 | ||||||||
|
arginine-glutamic acid dipeptide repeats | 0.526 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 3 | 2 | 2010 | 2016 | ||||||||
|
caspase 7 | 0.581 | 0.654 | 5.4E-05 |
|
disease | 0.400 | None | 1.000 | 1 | 1 | 2012 | 2016 | ||||||||
|
IKAROS family zinc finger 4 | 0.861 | 0.192 | 0.90 |
|
disease | 0.400 | None | 1.000 | 1 | 3 | 2012 | 2016 |